ANXA1 and neoplasm: On the other hand, the involvement of both ANXA1 and tumor-derived EVs as pro-angiogenic elements, already widely described in literature [18,66,67,68,69,70], confirm the previously described interaction of EV-containing ANXA1 with FPRs [17].